Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | ||
| Net Income | -5,194 | -5,071 |
| Depreciation Amortization | 831 | 467 |
| Income taxes - deferred | -9 | -14 |
| Accounts receivable | -7,921 | -2,887 |
| Accounts payable and accrued liabilities | 10,686 | 7,730 |
| Other Working Capital | -1,137 | -282 |
| Other Operating Activity | -2,143 | -4,623 |
| Operating Cash Flow | $-4,887 | $-4,680 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,488 | -910 |
| Investing Cash Flow | $-1,488 | $-910 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 50,566 | 20,510 |
| Debt Repayment | -44,702 | -15,738 |
| Common Stock Issued | 11 | 11 |
| Other Financing Activity | -48 | 18 |
| Financing Cash Flow | $5,827 | $4,801 |
| Beginning Cash Position | 1,581 | 1,581 |
| End Cash Position | 1,033 | 792 |
| Net Cash Flow | $-548 | $-789 |
| Free Cash Flow | ||
| Operating Cash Flow | -4,887 | -4,680 |
| Capital Expenditure | -1,488 | -910 |
| Free Cash Flow | -6,375 | -5,590 |